Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway

Oncogene

Volumn 26, Issue 2, 2007, Pages 284-289

  Ameri, K ^a   Hammond, E M ^a   Culmsee, C ^b   Raida, M ^c   Katschinski, D M ^d   Wenger, R H ^e   Wagner, E ^b   Davis, R J ^f   Hai, T ^g   Denko, N ^a   Harris, A L ^h  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^g OHIO STATE UNIVERSITY   (United States)

^h UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Anoxia; ATF3; HIF; Hypoxia; MKK7 JNK; p53

Indexed keywords

2 OXOGLUTARATE DIOXYGENASE; ACETYLCYSTEINE; ACTIVATING TRANSCRIPTION FACTOR 3; CYANIDE; DEFEROXAMINE; DIMETHYLOXALYLGLYCINE; ENZYME; ENZYME INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; OXYGEN; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANOXIA; ARTICLE; ENZYME ACTIVATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION;

ACETYLCYSTEINE; ACTIVATING TRANSCRIPTION FACTOR 3; AMINO ACIDS, DICARBOXYLIC; ANOXIA; BREAST NEOPLASMS; CELLS, CULTURED; CYANIDES; DEFEROXAMINE; ENZYME ACTIVATION; FREE RADICAL SCAVENGERS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MELANOMA; MIXED FUNCTION OXYGENASES; NEURONS; OXYGEN; PROTO-ONCOGENE PROTEINS C-JUN; SIDEROPHORES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 33846256974     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209781     Document Type: Article

References (41)

1. Alfranca A, Gutierrez MD, Vara A, Aragones J, Vidal F, Landazuri MO. (2002). Mol Cell Biol 22: 12-22.
2. Ameri K, Lewis CE, Raida M, Sowter H, Hai T, Harris AL. (2004). Blood 103: 1876-1882.
3. Amundson SA, Bittner M, Chen Y, Trent J, Meltzer P, Fornace Jr J. (1999). Oncogene 18: 3666-3672.
4. Blais JD, Filipenko V, Bi M, Harding HP, Ron D, Koumenis C et al. (2004). Mol Cell Biol 24: 7469-7482.
5. Bottone Jr FG, Moon Y, Alston-Mills B, Eling TE. (2005). J Pharmacol Exp Ther 315: 668-677.
6. Cai Y, Zhang C, Nawa T, Aso T, Tanaka M, Oshiro S et al. (2000). Blood 96: 2140-2148.
7. Chilov D, Camenisch G, Kvietikova I, Ziegler U, Gassmann M, Wenger RH. (1999). J Cell Sci 112(Part 8): 1203-1212.
8. Culmsee C, Siewe J, Junker V, Retiounskaia M, Schwarz S, Camandola S et al. (2003). J Neurosci 23: 8586-8595.
9. Elvidge GP, Glenny L, Appelhoff RJ, Ratcliffe PJ, Ragoussis J, Gleadle JM. (2006). J Biol Chem 281: 15215-15226.
10. Fan F, Jin S, Amundson SA, Tong T, Fan W, Zhao H et al. (2002). Oncogene 21: 7488-7496.
11. Francis JS, Dragunow M, During MJ. (2004). Brain Res Mol Brain Res 124: 199-203.
12. Goldberg-Cohen I, Furneauxb H, Levy AP. (2002). J Biol Chem 277: 13635-13640.
13. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW et al. (1996). Nature 379: 88-91.
14. Hai T, Hartman MG. (2001). Gene 273: 1-11.
15. Hai T, Wolfgang CD, Marsee DK, Allen AE, Sivaprasad U. (1999). Gene Exp 7: 321-335.
16. Hammond EM, Green SL, Giaccia AJ. (2003). Mutat Res 532: 205-213.
17. Hammond EM, Mandell DJ, Salim A, Krieg AJ, Johnson TM, Shirazi HA et al. (2006). Mol Cell Biol 26: 3492-3504.
18. Hartman MG, Lu D, Kim ML, Kociba GJ, Shukri T, Buteau J et al. (2004). Mol Cell Biol 24: 5721-5732.
19. Inoue K, Zama T, Kamimoto T, Aoki R, Ikeda Y, Kimura H et al. (2004). Genes Cells 9: 59-70.
20. Ishiguro T, Nagawa H. (2000). Oncol Res 12: 181-183.
21. Jiang BH, Rue E, Wang GL, Roe R, Semenza GL. (1996). J Biol Chem 271: 17771-17778.
22. Kaelin Jr WG. (2005). Cell Metab 1: 357-358.
23. Koumenis C, Alarcon R, Hammond E, Sutphin P, Hoffman W, Murphy M et al. (2001). Mol Cell Biol 21: 1297-1310.
24. Le QT, Denko NC, Giaccia AJ. (2004). Cancer Metastasis Rev 23: 293-310.
25. Liang G, Wolfgang CD, Chen BP, Chen TH, Hai T. (1996). J Biol Chem 271: 1695-1701.
26. Lu D, Wolfgang CD, Hai T. (2006). J Biol Chem 281: 10473-10481.
27. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME et al. (1999). Nature 399: 271-275.
28. Okamoto A, Iwamoto Y, Maru Y. (2006). Mol Cell Biol 26: 1087-1097.
29. Pan YX, Chen H, Kilberg MS. (2005). J Biol Chem 280: 34609-34616.
30. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. (2006). Cell Metab 3: 187-197.
31. Papandreou I, Krishna C, Kaper F, Cai D, Giaccia AJ, Denko NC. (2005). Cancer Res 65: 3171-3178.
32. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM et al. (2000). Cancer Res 60: 4010-4015.
33. Schofield CJ, Ratcliffe PJ. (2004). Nat Rev Mol Cell Biol 5: 343-354.
34. Scott PH, Paul A, Belham CM, Peacock AJ, Wadsworth RM, Gould GW et al. (1998). Am J Respir Crit Care Med 158: 958-962.
35. Tournier C, Dong C, Turner TK, Jones SN, Flavell RA, Davis RJ. (2001). Genes Dev 15: 1419-1426.
36. Tournier C, Whitmarsh AJ, Cavanagh J, Barrett T, Davis RJ. (1997). Proc Natl Acad Sci USA 94: 7337-7342.
37. Vecsey-Semjen B, Becker KF, Sinski A, Blennow E, Vietor I, Zatloukal K et al. (2002). Oncogene 21: 4646-4662.
38. Vengellur A, Phillips JM, Hogenesch JB, LaPres JJ. (2005). Physiol Genomics 22: 308-318.
39. Ventura JJ, Cogswell P, Flavell RA, Baldwin Jr AS, Davis RJ. (2004). Genes Dev 18: 2905-2915.
40. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T et al. (2006). Cell 124: 207-219.
41. Yan C, Lu D, Hai T, Boyd DD. (2005). EMBO J 24: 2425-2435.